Electra targets $342m IPO to fund hyperinflammatory syndrome drug’s pivotal trials
Business
•
September 15, 2026
•
3 views
Source: Yahoo Finance | https://finance.yahoo.com/rss/topstories - Read Original
Discussion (0)
Please log in to post a comment.
No comments yet. Be the first to share your thoughts!



